318 related articles for article (PubMed ID: 28138325)
1. B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Juric MK; Shevtsov M; Mozes P; Ogonek J; Crossland RE; Dickinson AM; Greinix HT; Holler E; Weissinger EM; Multhoff G
Front Immunol; 2016; 7():660. PubMed ID: 28138325
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
[TBL] [Abstract][Full Text] [Related]
3. [Effect of graft-versus-host disease on relapse and survival in 100 patients after allogeneic hematopoietic stem cell transplantation].
Deng XR; Ren HY; Cen XN; Wang LH; Liang ZY; Wang WS; Qiu ZX; Ou JP; Xu WL; Wang MJ; Li Y; Yin Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Aug; 17(4):994-8. PubMed ID: 19698246
[TBL] [Abstract][Full Text] [Related]
4. Elevated level of HSPA1L mRNA correlates with graft-versus-host disease.
Atarod S; Turner B; Pearce KF; Ahmed SS; Norden J; Bogunia-Kubik K; Wang XN; Collin M; Dickinson AM
Transpl Immunol; 2015 Jun; 32(3):188-94. PubMed ID: 25680846
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study on haploid HLA-matched hematopoietic stem cell transplantation for treatment of malignant hematological disease].
Sun AN; Wu DP; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Fu ZZ; Ma X; Han Y; He GS; Chen SN; Xue SL; Zhao Y
Ai Zheng; 2006 Aug; 25(8):1019-22. PubMed ID: 16965686
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of 104 patients with hematological malignancy after allogeneic hemotopoietic stem cell transplantation].
Chen Y; Xu Y; Zhu Y; Fu G; Liu Y; Peng J; Fu B; He Q; Wu D; Li X; Zhao X; Chen F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 36(9):859-64. PubMed ID: 21946205
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
10. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
12. Plasma-based protein biomarkers can predict the risk of acute graft-versus-host disease and non-relapse mortality in patients undergoing allogeneic hematopoietic stem cell transplantation.
Shin J; Dan K; Han D; Kim JW; Kim KK; Koh Y; Shin DY; Hong J; Yoon SS; Park S; Song SH; Kim I
Blood Cells Mol Dis; 2019 Feb; 74():5-12. PubMed ID: 30344086
[TBL] [Abstract][Full Text] [Related]
13. [Impact of graft versus host disease on outcome of allogeneic peripherial blood stem cell transplantation for leukemia].
Li M; Zhang W; Wang J; Song X; Yang J; Ni X; Yang D; Chen L; Chen J; Hu X; Gao L; Qiu H; Zhou H; Cheng H
Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):428-33. PubMed ID: 24857214
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-versus-host disease in a nonhematopoietic stem cell transplantation candidate treated with decitabine followed by granulocyte colony-stimulating factor-primed peripheral blood stem cells infusion: a special entity of the disease?
Yuan L; Sun L; Yang L; Jing Y
Transfusion; 2014 Jan; 54(1):190-3. PubMed ID: 23621702
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between serum levels of IL-18 and acute graft versus host disease in patients after allogeneic hematopoietic stem cell transplantation].
Liu J; Zhang XG; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):553-7. PubMed ID: 17605864
[TBL] [Abstract][Full Text] [Related]
16. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between Plasma microRNA Expression and Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation].
Hu B; Fu W; Huang SY; Gao XT; Li DH; Yan XQ; Zhang YP; Liu Q; Liu L; Liang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):827-32. PubMed ID: 27342518
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-tumor effect according to type of graft-versus-host disease defined by National Institutes of Health consensus criteria and associated outcomes.
Cho BS; Lee SE; Song HH; Lee JH; Yahng SA; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1136-43. PubMed ID: 22261380
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
Wang Y; Zhao X; Ye X; Luo H; Zhao T; Diao Y; Zhang H; Lv M; Zhang W; Huang X; Wan J
Ann Hematol; 2015 Sep; 94(9):1505-14. PubMed ID: 26051902
[TBL] [Abstract][Full Text] [Related]
20. miR-146a and miR-155 Expression Levels in Acute Graft-Versus-Host Disease Incidence.
Atarod S; Ahmed MM; Lendrem C; Pearce KF; Cope W; Norden J; Wang XN; Collin M; Dickinson AM
Front Immunol; 2016; 7():56. PubMed ID: 27014257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]